Fig. 7From: Dersimelagon, a novel oral melanocortin 1 receptor agonist, demonstrates disease-modifying effects in preclinical models of systemic sclerosisMechanism of action of MT-7117 in systemic sclerosis. Schematic diagram illustrating the mechanism of MT-7117 based on findings of the present studyBack to article page